Campylobacter jejuni Enteritis

1. Executive Overview: Understanding Campylobacter jejuni Enteritis

Campylobacter jejuni enteritis is one of the most common causes of bacterial gastroenteritis worldwide. Classified under ICD-10 code A04.5, this infection is a significant public health concern, often associated with the consumption of contaminated poultry, unpasteurized milk, or untreated water.

Clinically, C. jejuni is a gram-negative, microaerophilic, spiral-shaped bacterium that preferentially colonizes the intestinal mucosa. While often self-limiting, the infection can present with severe abdominal distress, mimicking acute appendicitis or inflammatory bowel disease (IBD). Understanding the nuances of this pathogen is critical for gastroenterologists and primary care physicians to ensure timely diagnosis and prevent potential long-term neurological sequelae, such as Guillain-Barré syndrome (GBS).

2. Pathophysiology, Etiology, and Risk Factors

The Etiology of Infection

C. jejuni is zoonotic, with the primary reservoir being the intestinal tracts of birds and livestock. Humans become infected through the ingestion of contaminated food products. The organism is highly adapted to the avian gut environment (temperature ~42°C), which allows it to thrive during the processing of poultry.

Pathophysiological Mechanisms

The virulence of C. jejuni is multifaceted, relying on several key mechanisms:

• Motility: The bacterium utilizes polar flagella to penetrate the thick mucus layer of the intestinal epithelium.
• Adhesion and Invasion: Surface proteins (e.g., CadF) facilitate binding to host cells, while the cytolethal distending toxin (CDT) induces cell cycle arrest and apoptosis in epithelial cells.
• Inflammatory Response: The host immune response—characterized by the infiltration of neutrophils and mononuclear cells—leads to the disruption of the brush border, resulting in malabsorption and exudative diarrhea.

Risk Factors

3. Signs, Symptoms, and Clinical Presentation

The incubation period for C. jejuni typically ranges from 2 to 5 days. The clinical progression is often biphasic, starting with prodromal symptoms followed by acute enteritis.

Classic Symptomatology

1. Abdominal Pain: Often severe and localized to the right lower quadrant, frequently leading to the misdiagnosis of acute appendicitis.
2. Diarrhea: Ranges from watery stools to frank dysentery (bloody, mucoid stools).
3. Systemic Symptoms: High-grade fever, malaise, myalgia, and generalized headache.
4. Duration: Symptoms typically persist for 5–7 days in immunocompetent hosts, though bacterial shedding may continue for weeks.

Differential Diagnosis

Clinicians must distinguish C. jejuni from other infectious causes of colitis:
* Salmonella and Shigella species.
* Escherichia coli (EHEC/EIEC).
* Clostridioides difficile infection.
* Acute surgical abdomen (Appendicitis, IBD flare).

4. Standard Diagnostic Evaluation & Workup

Accurate diagnosis is paramount, particularly in patients with severe disease or underlying comorbidities.

Laboratory Assays

• Stool Culture: The gold standard. Requires selective media (e.g., Skirrow’s or Campy-BAP) and incubation in a microaerophilic atmosphere at 42°C.
• Molecular Diagnostics (PCR): Increasingly favored due to higher sensitivity and faster turnaround times. Multiplex PCR panels can detect Campylobacter alongside other enteric pathogens in under 2 hours.
• Antigen Testing: Enzyme immunoassays (EIA) for fecal Campylobacter antigens are useful for rapid point-of-care screening.

Imaging and Invasive Procedures

• Abdominal Ultrasound/CT: Indicated if the patient presents with severe right lower quadrant pain to rule out appendicitis or mesenteric adenitis. Findings may show terminal ileitis or thickened colonic walls.
• Colonoscopy/Sigmoidoscopy: Generally reserved for cases where IBD is suspected. Histopathology typically reveals acute inflammation, crypt abscesses, and focal ulceration.

5. Therapeutic Interventions

Pharmacotherapy

Most cases of Campylobacter enteritis are self-limiting and require only supportive care. Antibiotics are reserved for patients with high fever, bloody stools, or immunocompromise.

• First-Line Treatment: Macrolides (e.g., Azithromycin 500mg daily for 3 days).
• Alternative/Second-Line: Fluoroquinolones (e.g., Ciprofloxacin). Note: Increasing resistance to fluoroquinolones has been observed globally, making macrolides the preferred choice.

Supportive Care

• Hydration: Oral rehydration therapy (ORT) is the cornerstone of management. Intravenous fluids are indicated for patients with signs of severe dehydration or hemodynamic instability.
• Nutritional Support: Early resumption of a bland diet is encouraged once vomiting subsides.

Long-term Prognosis and Complications

While the prognosis is excellent for most, rare but serious complications can occur:
* Guillain-Barré Syndrome (GBS): An autoimmune polyneuropathy triggered by molecular mimicry between C. jejuni lipooligosaccharides and human peripheral nerve gangliosides.
* Reactive Arthritis: A sterile inflammatory joint condition occurring post-infection.
* Post-Infectious IBS: Chronic bowel dysfunction following acute infection.

6. Frequently Asked Questions (FAQ)

1. Is Campylobacter jejuni considered a foodborne illness?
Yes, it is one of the most common causes of foodborne bacterial gastroenteritis worldwide, primarily linked to contaminated poultry.

2. How long does the infection typically last?
In healthy individuals, symptoms usually resolve within 5 to 7 days, though some patients may experience symptoms for up to 10 days.

3. Can Campylobacter infection cause long-term nerve damage?
Yes, it is a known trigger for Guillain-Barré Syndrome (GBS), a rare autoimmune condition where the immune system attacks the nerves.

4. Do I always need antibiotics for this infection?
No. Antibiotics are generally reserved for severe cases, immunocompromised patients, or individuals with prolonged symptoms.

5. How is the infection diagnosed in a lab?
Diagnosis is typically made via stool culture, molecular PCR assays, or rapid fecal antigen testing.

6. Can I return to work or school immediately?
It is recommended to stay home until diarrhea has stopped for at least 48 hours to prevent the spread of the bacteria.

7. Is Campylobacter jejuni contagious?
Yes, it spreads through the fecal-oral route, primarily via contaminated food/water or direct contact with infected animals.

8. What is the best way to prevent this infection?
Proper cooking of poultry to an internal temperature of 165°F (74°C), pasteurizing milk, and frequent handwashing are the most effective preventive measures.

9. Why does it mimic appendicitis?
C. jejuni often causes inflammation of the terminal ileum and mesenteric lymph nodes, which produces pain in the right lower quadrant, mirroring the symptoms of appendicitis.

10. What should I do if I suspect I have an infection?
Seek medical attention if you experience high fever, bloody stools, persistent vomiting, or signs of severe dehydration. Do not self-medicate with anti-diarrheal agents without consulting a physician.

Related Clinical Integration

In the management of Campylobacter jejuni enteritis, clinical intervention is primarily supportive, focusing on fluid and electrolyte replacement; however, antimicrobial therapy is reserved for patients with severe symptoms, high-risk comorbidities, or prolonged illness. When systemic treatment is indicated to shorten the duration of fecal shedding and alleviate clinical symptoms, Erythromycin / إريثروميسين 250mg serves as a preferred therapeutic agent due to its efficacy against Campylobacter species. Clinicians should integrate the administration of Erythromycin / إريثروميسين 250mg within the hospital’s electronic prescribing workflow to ensure appropriate dosing and monitoring, particularly in cases where antibiotic resistance patterns or patient-specific factors necessitate targeted pharmacological support.